etoposide has been researched along with Movement Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, AP; Mao, RR; Xu, L; Yang, YX; Yu, CL; Zhou, H | 1 |
Garbash, M; Pandya, N; Rajamoorthy, V; Schofield, J; Tambe, S | 1 |
Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
Caglar, M; Ersoy, F; Gunay, M; Gurgey, A; Kale, G; Kucukali, T; Sayli, T | 1 |
4 other study(ies) available for etoposide and Movement Disorders
Article | Year |
---|---|
Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Infarction; Brain Ischemia; Disease Models, Animal; Etoposide; Exercise Test; Ifosfamide; Intracranial Thrombosis; Lasers; Locomotion; Male; Methotrexate; Mice; Mice, Inbred Strains; Movement Disorders; Rotarod Performance Test; Wakefulness | 2015 |
An unusual cause of limp.
Topics: Antineoplastic Agents, Phytogenic; Child; Dexamethasone; Diagnosis, Differential; Diagnostic Imaging; Drug Therapy, Combination; Etoposide; Female; Glucocorticoids; Humans; Lymphohistiocytosis, Hemophagocytic; Movement Disorders | 2012 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement.
Topics: Albinism; Central Nervous System Diseases; Child; Etoposide; Female; Fever; Humans; Leukopenia; Methylprednisolone; Movement Disorders; Syndrome; Thrombocytopenia | 1994 |